HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102

Clinical trial NCT03519113 · UNKNOWN

Trial details

NCT number: NCT03519113
Sponsor: Green Cross Corporation
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hepatitis B Infection

Start date: 2018-03-29
Primary completion: 2022-03-31
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.